🇺🇸 FDA
Pipeline program

Fluticasone furoate (FF) (100 mcg)

201499

Phase 2 small_molecule completed

Quick answer

Fluticasone furoate (FF) (100 mcg) for Asthma is a Phase 2 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline
Indication
Asthma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials